In high-risk type 2 diabetes, adding oral semaglutide to standard care reduced MACE at a mean 48 mo. Bandi SSS, Montori VM. Ann Intern Med 2025 Jul 1. doi: 10.7326/ANNALS-25-02173.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bandi SSS, Montori VM. In high-risk type 2 diabetes, adding oral semaglutide to standard care reduced MACE at a mean 48 mo. Ann Intern Med 2025 Jul 1. doi: 10.7326/ANNALS-25-02173.
PMID: 40587855